Literature DB >> 24439222

Comparison of the Haas and the Oxford classifications for prediction of renal outcome in patients with IgA nephropathy.

Kyoung Sook Park1, Seung Hyeok Han1, Jeong Hae Kie2, Ki Heon Nam1, Mi Jung Lee1, Beom Jin Lim3, Young Eun Kwon1, Yung Ly Kim1, Seong Yeong An1, Chan Ho Kim1, Fa Mee Doh1, Hyang Mo Koo1, Hyung Jung Oh1, Shin-Wook Kang4, Kyu Hun Choi1, Hyeon Joo Jeong3, Tae-Hyun Yoo5.   

Abstract

Pathologic features can provide valuable information for determining prognosis in IgA nephropathy (IgAN). However, it is uncertain whether the Oxford classification, a new classification of IgAN, can predict renal outcome better than previous ones. We conducted a retrospective cohort study in 500 patients with biopsy-proven IgAN between January 2002 and December 2010 to compare the ability of the Haas and the Oxford classifications to predict renal outcome. Primary outcome was a doubling of the baseline serum creatinine concentration (D-SCr). During a mean follow-up of 68 months, 52 (10.4%) and 35 (7.0%) developed D-SCr and end-stage renal disease, respectively. There were graded increases in the development of D-SCr in the higher Haas classes. In addition, the primary endpoint of D-SCr occurred more in patients with the Oxford M and T lesions than those without such lesions. In multivariate Cox regression analyses, the Haas class V (HR, 12.19; P=.002) and the Oxford T1 (hazard ratio [HR], 6.68; P<.001) and T2 (HR, 12.16; P<.001) lesions were independently associated with an increased risk of reaching D-SCr. Harrell's C index of each multivariate model with the Haas and the Oxford classification was 0.867 (P=.015) and 0.881 (P=.004), respectively. This was significantly higher than that of model with clinical factors only (C=0.819). However, there was no difference in C-statistics between the 2 models with the Haas and the Oxford classifications (P=.348). This study suggests that the Haas and the Oxford classifications are comparable in predicting progression of IgAN.
© 2014.

Entities:  

Keywords:  IgA nephropathy; Long-term outcome; Proteinuria

Mesh:

Substances:

Year:  2014        PMID: 24439222     DOI: 10.1016/j.humpath.2013.08.019

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

1.  Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.

Authors:  Aron Chakera; Clare MacEwen; Shubha S Bellur; La-Or Chompuk; Daniel Lunn; Ian S D Roberts
Journal:  J Nephrol       Date:  2015-08-30       Impact factor: 3.902

Review 2.  Pathology of IgA nephropathy.

Authors:  Ian S D Roberts
Journal:  Nat Rev Nephrol       Date:  2014-05-27       Impact factor: 28.314

3.  Glomerular epithelial CD44 expression and segmental sclerosis in IgA nephropathy.

Authors:  Sewha Kim; Yon Hee Kim; Kyu Hun Choi; Hyeon Joo Jeong
Journal:  Clin Exp Nephrol       Date:  2015-12-28       Impact factor: 2.801

4.  Distribution of Streptococcus mutans strains with collagen-binding proteins in the oral cavity of IgA nephropathy patients.

Authors:  Taro Misaki; Shuhei Naka; Keiko Kuroda; Ryota Nomura; Tempei Shiooka; Yoshitaka Naito; Yumiko Suzuki; Hideo Yasuda; Taisuke Isozaki; Kazuhiko Nakano
Journal:  Clin Exp Nephrol       Date:  2014-12-10       Impact factor: 2.801

5.  Usefulness of the delta neutrophil index to predict 30-day mortality in patients with ST segment elevation myocardial infarction.

Authors:  Taeyoung Kong; Tae Hoon Kim; Yoo Seok Park; Sung Phil Chung; Hye Sun Lee; Jung Hwa Hong; Jong Wook Lee; Je Sung You; Incheol Park
Journal:  Sci Rep       Date:  2017-11-16       Impact factor: 4.379

6.  Clinical impact of endocapillary proliferation with modified cutoff points in IgA nephropathy patients.

Authors:  Ahmad Baseer Kaihan; Yoshinari Yasuda; Takahiro Imaizumi; Koji Inagaki; Takaya Ozeki; Manabu Hishida; Takayuki Katsuno; Naotake Tsuboi; Shoichi Maruyama
Journal:  PLoS One       Date:  2019-03-29       Impact factor: 3.240

7.  Assessment of active tubulointerstitial nephritis in non-scarred renal cortex improves prediction of renal outcomes in patients with IgA nephropathy.

Authors:  Alastair J Rankin; David Kipgen; Colin C Geddes; Jonathan G Fox; Gordon Milne; Bruce Mackinnon; Emily P McQuarrie
Journal:  Clin Kidney J       Date:  2018-10-10

8.  Utilizing the MEST score for prognostic staging in IgA nephropathy.

Authors:  Yngvar Lunde Haaskjold; Rune Bjørneklett; Leif Bostad; Lars Sigurd Bostad; Njål Gjærde Lura; Thomas Knoop
Journal:  BMC Nephrol       Date:  2022-01-11       Impact factor: 2.388

9.  The Association of the Oxford Classification Score with Longitudinal Estimated Glomerular Filtration Rate Decline in Patients with Immunoglobulin A Nephropathy: A Mixed-Method Study.

Authors:  Ricong Xu; Zhijian Li; Tao Cao; Yi Xu; Ying Liao; Haiying Song; Xiaojie Chen; Fei Tang; Qiong Xiang; Qijun Wan
Journal:  Int J Gen Med       Date:  2021-06-18

Review 10.  Has The Time Arrived to Refine The Indications of Immunosuppressive Therapy and Prognosis in IgA Nephropathy?

Authors:  Bogdan Obrișcă; Ioanel Sinescu; Gener Ismail; Gabriel Mircescu
Journal:  J Clin Med       Date:  2019-10-02       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.